5.jpg

Remy Sukhija, Interim CEO, ODH, Inc.

    Remy Sukhija Interim CEO ODH IncRemy Sukhija is interim CEO of ODH, Inc., a health technology company providing data aggregation and analytics solutions that enable the delivery of integrated health care. He oversees ODH’s overall operations and drives strategy for its flagship product, Mentrics®, a clinically-focused technology platform that integrates social determinants, behavioral, physical, pharmacy and other health data into actionable insights for the health industry.

    With more than 25 years of experience in biotechnology, pharmaceuticals and venture-backed start-ups, Remy has a proven track record of growing businesses, maximizing revenues and successfully leading commercialization and product launch initiatives. He has extensive management experience in marketing, sales, program leadership, business development and analytics.

    For the past two years, Remy has served as senior vice president for commercial operations for Otsuka America Pharmaceutical, Inc., a sister company of ODH, a role he continues to perform. Previously, he served as chief operating officer at Merganser Biotech, a venture-backed biotech firm. Before that, he built and led the hemophilia business unit at Biogen which resulted in successful product launches. Remy has also held various commercial and operational leadership roles at Pfizer and GSK.

    Remy earned his bachelor of science degree in business from The University of Akron.

    Remy Sukhija LinkedIn    Follow and connect with Remy Sukhija on LinkedIn.